Xvivo Perfusion Ab (publ)
(OTC) XVIPF
Xvivo Perfusion Ab (publ) Financials at a Glance
Market Cap
$603.22M
Revenue (TTM)
$810.29M
Net Income (TTM)
$25.05M
EPS (TTM)
$0.09
P/E Ratio
213.73
Dividend
$0.00
Beta (Volatility)
0.30 (Low)
Dividend
$0.00
Beta (Volatility)
0.30 (Low)
Price
$19.15
Volume
200
Open
$19.33
Price
$19.15
Volume
200
Open
$19.33
Previous Close
$19.15
Daily Range
$19.15 - $19.33
52-Week Range
$16.98 - $37.83
Dividend
$0.00
Beta (Volatility)
0.30 (Low)
Price
$19.15
Volume
200
Open
$19.33
Previous Close
$19.15
Daily Range
$19.15 - $19.33
52-Week Range
$16.98 - $37.83
XVIPF News
XVIPF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Xvivo Perfusion Ab (publ)
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
198
CEO
Christoffer Rosenblad, MBA
Website
www.xvivoperfusion.comHeadquarters
Gothenburg, 412 51, SE
XVIPF Financials
Key Financial Metrics (TTM)
Gross Margin
66%
Operating Margin
11%
Net Income Margin
3%
Return on Equity
1%
Return on Capital
4%
Return on Assets
1%
Earnings Yield
0.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$603.22M
Shares Outstanding
31.50M
Volume
200
Short Interest
0.00%
Avg. Volume
90.902
Financials (TTM)
Gross Profit
$532.16M
Operating Income
$92.78M
EBITDA
$152.75M
Operating Cash Flow
$100.81M
Capital Expenditure
$100.81M
Free Cash Flow
$0.00
Cash & ST Invst.
$291.36M
Total Debt
$237.29M
Xvivo Perfusion Ab (publ) Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$225.58M
-0.9%
Gross Profit
$146.01M
-16.6%
Gross Margin
64.73%
N/A
Market Cap
$603.22M
N/A
Market Cap/Employee
$3.13M
N/A
Employees
193
N/A
Net Income
$31.57M
-13.2%
EBITDA
$60.31M
+290.0%
Quarterly Fundamentals
Net Cash
$54.07M
-85.8%
Accounts Receivable
$147.29M
+11.5%
Inventory
$247.83M
+9.0%
Long Term Debt
$225.76M
+876.2%
Short Term Debt
$11.53M
+5.6%
Return on Assets
1.06%
N/A
Return on Invested Capital
4.13%
N/A
Free Cash Flow
$0.00
-100.0%
Operating Cash Flow
$86.71M
+39.7%